Cartesian Therapeutics In...

NASDAQ: RNAC · Real-Time Price · USD
11.58
0.25 (2.21%)
At close: Aug 18, 2025, 10:55 AM

Cartesian Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-36.26M -38.31M -77.42M -244.83M -229.65M -254.87M -219.71M -36.16M -35.05M -15.06M 35.38M 41.73M 31.72M 27.69M -25.69M -53.37M -45.21M -73.85M
Depreciation & Amortization
2.53M 2.14M 1.17M 951K 840K 820K 843K 1.18M 1.53M 1.85M 2.29M 2M 2.09M 2.17M 2.01M 1.93M 1.44M 982K
Stock-Based Compensation
9.35M 7.66M 6.58M 18.86M 19.49M 21.68M 22.52M 8.38M 6.06M 2.28M n/a n/a n/a n/a n/a 1.24M 2.53M 4.01M
Other Working Capital
654K -8.64M -10.84M -15.26M -14.74M -14.11M 5.26M 3.22M -10.22M -22.93M -60.63M -90.23M -89.23M -83.68M -61.11M -33.16M 71.41M 82.2M
Other Non-Cash Items
-42.21M 4.15M 51.79M 76.52M 66.81M 65.36M 20.51M -5.63M -12.31M 13.24M -4.59M 1.23M 7.74M -19.45M 18.41M 27.26M 23.24M 32.12M
Deferred Income Tax
n/a n/a n/a 125.09M 122.04M 115.7M 119.7M -5.39M -2.34M 4M n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
32.66M -6.5M -5.79M -16.55M -42.39M -7M 4.97M 1.84M 4.22M -29.01M -60.38M -91.21M -88.56M -67.01M -48.19M -10.91M 61.86M 73.11M
Operating Cash Flow
-33.94M -30.86M -23.67M -39.96M -62.86M -58.31M -51.16M -39.72M -26.16M -28.53M -31.63M -51.24M -66.34M -60.11M -60.38M -36.17M 40.21M 34.45M
Capital Expenditures
-10.57M -9.57M -9.09M -8.45M -2.25M -678K -206K -353K -789K -876K -1.2M -1.27M -996K -1.51M -1.08M -997K -1.12M -705K
Cash Acquisitions
n/a n/a n/a 6.56M 6.56M 6.56M 6.56M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a -33.5M -33.5M -33.5M -33.5M -8.04M -10.04M -32.45M -32.45M -24.42M -22.42M
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a 28.25M 33.95M 37.95M 37.95M 19.7M 24M 26.4M 26.4M 16.4M 6.4M n/a n/a
Other Investing Acitivies
351K 351K 351K 6.56M 6.56M 6.56M 6.56M n/a n/a n/a n/a n/a n/a n/a n/a 24K 29K 74K
Investing Cash Flow
-10.22M -9.21M -8.74M -1.89M 4.31M 5.88M 34.61M 33.6M 3.66M 3.58M -15M -10.77M 17.37M 14.85M -17.14M -27.03M -25.51M -23.05M
Debt Repayment
n/a n/a n/a n/a -24.87M -24.87M -24.87M -24.87M n/a n/a n/a n/a n/a n/a n/a -102K 9.62M 7.52M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
117.31M 117.37M 128.43M 147.9M 23.4M 20.7M 17.81M -2.33M -2.13M 456K 345K 339K 233K 661K 939K 777K 1.64M 1.36M
Financial Cash Flow
117.31M 117.37M 168.43M 181.73M 32.44M 29.74M -13.14M -27.23M -1.82M 37.64M 39.22M 60.37M 61.21M 33.32M 52.9M 31.55M 51.05M 41.11M
Net Cash Flow
73.16M 77.31M 135.99M 139.89M -26.11M -22.73M -29.75M -33.17M -24.36M 12.78M -7.33M -1.8M 12.31M -11.98M -24.63M -31.62M 65.73M 52.53M
Free Cash Flow
-44.51M -40.43M -32.77M -48.41M -65.12M -58.99M -51.37M -40.08M -26.95M -29.41M -32.83M -52.51M -67.34M -61.63M -61.47M -37.17M 39.09M 33.74M